Journal Summary - Discover more summaries and articles from M3 India

Journal Summaries

Allergy and Immunology

Vaccine/Immunotherapy

A 12-year follow-up on the long-term effectiveness of the quadrivalent human papillomavirus vaccine in 4 Nordic countries

Clinical Infectious Diseases | Jan 22, 2018 Vaccine/Immunotherapy

Randomized clinical trial of a single vs a double dose of 13-valent pneumococcal conjugate vaccine in adults 55 through 74 years of age previously vaccinated with 23-valent pneumococcal polysaccharide vaccine

Vaccine | Jan 22, 2018 Vaccine/Immunotherapy

Safety and efficacy of immunotherapy with the recombinant B-cell epitope–based grass pollen vaccine BM32

The Journal of Allergy and Clinical Immunology | Jan 20, 2018 Vaccine/Immunotherapy

Pre-vaccine plasma levels of soluble inflammatory indices negatively predict responses to HAV, HBV, and tetanus vaccines in HCV and HIV infection

Vaccine | Jan 20, 2018 Vaccine/Immunotherapy

Safety of vaccines that have been kept outside of recommended temperatures: Reports to the Vaccine Adverse Event Reporting System (VAERS), 2008–2012

Vaccine | Jan 18, 2018 Vaccine/Immunotherapy

Lolium perenne peptide immunotherapy is well tolerated and elicits a protective B-cell response in seasonal allergic rhinitis patients

Allergy | Jan 17, 2018 Vaccine/Immunotherapy

Low-dose oral immunotherapy using low-egg-allergen cookies for severe egg-allergic children reduces allergy severity and affects allergen-specific antibodies in serum

International Archives of Allergy and Immunology | Jan 17, 2018 Vaccine/Immunotherapy

Trends in rate of seizure-associated hospitalizations among children <5 years old before and after rotavirus vaccine introduction in the United States, 2000–2013

The Journal of Infectious Diseases | Jan 14, 2018 Vaccine/Immunotherapy

Vaccination titres pre- and post-transplant in paediatric renal transplant recipients and the impact of immunosuppressive therapy

Pediatric Nephrology | Jan 13, 2018 Vaccine/Immunotherapy

The impact of the 13-valent pneumococcal conjugate vaccine on pneumococcal carriage in the Community Acquired Pneumonia Immunization Trial in Adults (CAPiTA) Study

Clinical Infectious Diseases | Jan 11, 2018 Vaccine/Immunotherapy

« Prev 1 … 29 30 31 32 33 … 42 Next »

A 12-year follow-up on the long-term effectiveness of the quadrivalent human papillomavirus vaccine in 4 Nordic countries

Randomized clinical trial of a single vs a double dose of 13-valent pneumococcal conjugate vaccine in adults 55 through 74 years of age previously vaccinated with 23-valent pneumococcal polysaccharide vaccine

Safety and efficacy of immunotherapy with the recombinant B-cell epitope–based grass pollen vaccine BM32

Pre-vaccine plasma levels of soluble inflammatory indices negatively predict responses to HAV, HBV, and tetanus vaccines in HCV and HIV infection

Safety of vaccines that have been kept outside of recommended temperatures: Reports to the Vaccine Adverse Event Reporting System (VAERS), 2008–2012

Lolium perenne peptide immunotherapy is well tolerated and elicits a protective B-cell response in seasonal allergic rhinitis patients

Low-dose oral immunotherapy using low-egg-allergen cookies for severe egg-allergic children reduces allergy severity and affects allergen-specific antibodies in serum

Trends in rate of seizure-associated hospitalizations among children <5 years old before and after rotavirus vaccine introduction in the United States, 2000–2013

Vaccination titres pre- and post-transplant in paediatric renal transplant recipients and the impact of immunosuppressive therapy

The impact of the 13-valent pneumococcal conjugate vaccine on pneumococcal carriage in the Community Acquired Pneumonia Immunization Trial in Adults (CAPiTA) Study

Enhancing Conventional Diabetes Management with Lifestyle and Nutritional Interventions

The Impact of Hormonal Imbalances on Women's Health

Anaesthetic Management in Obese Patients

Addressing Sleep Disorders with Integrative Solutions: From Pharmaceuticals to Natural Remedies

Gut Health Disorders and its Management

A 12-year follow-up on the long-term effectiveness of the quadrivalent human papillomavirus vaccine in 4 Nordic countries

Randomized clinical trial of a single vs a double dose of 13-valent pneumococcal conjugate vaccine in adults 55 through 74 years of age previously vaccinated with 23-valent pneumococcal polysaccharide vaccine

Safety and efficacy of immunotherapy with the recombinant B-cell epitope–based grass pollen vaccine BM32

Pre-vaccine plasma levels of soluble inflammatory indices negatively predict responses to HAV, HBV, and tetanus vaccines in HCV and HIV infection

Safety of vaccines that have been kept outside of recommended temperatures: Reports to the Vaccine Adverse Event Reporting System (VAERS), 2008–2012

Lolium perenne peptide immunotherapy is well tolerated and elicits a protective B-cell response in seasonal allergic rhinitis patients

Low-dose oral immunotherapy using low-egg-allergen cookies for severe egg-allergic children reduces allergy severity and affects allergen-specific antibodies in serum

Trends in rate of seizure-associated hospitalizations among children <5 years old before and after rotavirus vaccine introduction in the United States, 2000–2013

Vaccination titres pre- and post-transplant in paediatric renal transplant recipients and the impact of immunosuppressive therapy

The impact of the 13-valent pneumococcal conjugate vaccine on pneumococcal carriage in the Community Acquired Pneumonia Immunization Trial in Adults (CAPiTA) Study

Enhancing Conventional Diabetes Management with Lifestyle and Nutritional Interventions

The Impact of Hormonal Imbalances on Women's Health

Anaesthetic Management in Obese Patients

Addressing Sleep Disorders with Integrative Solutions: From Pharmaceuticals to Natural Remedies

Gut Health Disorders and its Management

Select Specialty

Select Topic